Lexaria Fixed Asset Turnover from 2010 to 2025

LEXX Stock  USD 1.47  0.08  5.16%   
Lexaria Bioscience Fixed Asset Turnover yearly trend continues to be fairly stable with very little volatility. Fixed Asset Turnover will likely drop to 0.30 in 2025. During the period from 2010 to 2025, Lexaria Bioscience Fixed Asset Turnover regression line of annual values had r-squared of  0.01 and arithmetic mean of  30.56. View All Fundamentals
 
Fixed Asset Turnover  
First Reported
2010-12-31
Previous Quarter
0.32022978
Current Value
0.3
Quarterly Volatility
85.85151019
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Lexaria Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lexaria Bioscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 129 K, Interest Expense of 107.8 K or Other Operating Expenses of 7.5 M, as well as many indicators such as Price To Sales Ratio of 140, Dividend Yield of 0.0 or PTB Ratio of 57.61. Lexaria financial statements analysis is a perfect complement when working with Lexaria Bioscience Valuation or Volatility modules.
  
Check out the analysis of Lexaria Bioscience Correlation against competitors.

Latest Lexaria Bioscience's Fixed Asset Turnover Growth Pattern

Below is the plot of the Fixed Asset Turnover of Lexaria Bioscience Corp over the last few years. It is Lexaria Bioscience's Fixed Asset Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lexaria Bioscience's overall financial position and show how it may be relating to other accounts over time.
Fixed Asset Turnover10 Years Trend
Pretty Stable
   Fixed Asset Turnover   
       Timeline  

Lexaria Fixed Asset Turnover Regression Statistics

Arithmetic Mean30.56
Geometric Mean3.97
Coefficient Of Variation280.97
Mean Deviation40.43
Median16.45
Standard Deviation85.85
Sample Variance7,370
Range350
R-Value(0.11)
Mean Square Error7,794
R-Squared0.01
Significance0.67
Slope(2.06)
Total Sum of Squares110,557

Lexaria Fixed Asset Turnover History

2025 0.3
2024 0.32
2023 1.19
2022 0.54
2021 0.69
2020 1.57
2019 0.63

About Lexaria Bioscience Financial Statements

Lexaria Bioscience investors use historical fundamental indicators, such as Lexaria Bioscience's Fixed Asset Turnover, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Lexaria Bioscience. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Fixed Asset Turnover 0.32  0.30 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Lexaria Stock Analysis

When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.